1.
J Pediatr
; 167(6): 1454-5, 2015 Dec.
Article
in English
| MEDLINE
| ID: mdl-26434371
2.
J Pediatr
; 167(3): 757-61.e1, 2015 Sep.
Article
in English
| MEDLINE
| ID: mdl-26165442
ABSTRACT
K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.